Archives

Maipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis

B SCARSDALE, N.Y., May 14, 2026 /PRNewswire/ — Maipl Therapeutics today highlighted continued preclinical progress for MA-4604, its lead investigational therapy for endometriosis. MA-4604 is a… Login to continue reading Login…

Read MoreMaipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis

TransCelerate Research Examines the Role of Digital Health Technologies in Patient Safety, Published in DIA’s Therapeutic Innovation & Regulatory Science

B Peer-reviewed manuscript highlights regulatory gaps, industry challenges, and opportunities to strengthen pharmacovigilance as digital health technology adoption accelerates PHILADELPHIA, May 14, 2026 /PRNewswire/ —… Login to continue reading Login…

Read MoreTransCelerate Research Examines the Role of Digital Health Technologies in Patient Safety, Published in DIA’s Therapeutic Innovation & Regulatory Science